-
Do Xpert MTB/RIF Cycle Threshold Values Provide Information about Patient Del...
INTRODUCTION: Early diagnosis and initiation to appropriate treatment is vital for tuberculosis (TB) control. The XpertMTB/RIF (Xpert) assay... -
Diagnostic accuracy of the Xpert MTB/RIF assay for bone and joint tuberculosi...
Background This study aimed to evaluate the accuracy of the Xpert MTB/RIF assay for the diagnosis of bone and joint tuberculosis. Methods We searched databases from their... -
An attempt to reproduce a previous meta-analysis and a new analysis regarding...
: Directly observed therapy (DOT) is almost universally used for the treatment of TB. Several meta-analyses using different methods have assessed the effectiveness of DOT... -
Efficacy of a New Educational Tool to Improve Handrubbing Technique amongst H...
INTRODUCTION: Hand hygiene is a key component of infection control in healthcare. WHO recommends that healthcare workers perform six specific poses during each hand hygiene... -
Patients Are Paying Too Much for Tuberculosis: A Direct Cost-Burden Evaluatio...
Paying for health care may exclude poor people. Burkina Faso adopted the DOTS strategy implementing "free care" for Tuberculosis (TB) diagnosis and treatment. This should... -
Predicting the impact of patient and private provider behavior on diagnostic ...
Background Tuberculosis (TB) incidence in India continues to be high due, in large part, to long delays experienced by patients before successful diagnosis and treatment... -
Development of new TB regimens : harmonizing trial design, product registrati...
International audience; • Regulatory approval of new tuberculosis (TB) drugs can be based on data from trial(s) using a surrogate endpoint of treatment efficacy under an... -
An open source pharma roadmap
In an Essay, Matthew Todd and colleagues discuss an open source approach to drug development. -
Blood Agar Validation for Susceptibility Testing of Isoniazid, Rifampicin, Et...
In recent studies, it was shown that blood agar can be used at least as effectively as Lowenstein-Jensen medium for growing Mycobacterium tuberculosis. It was also shown that... -
A novel strategy for interpreting the T-SPOT.TB test results read by an ELISP...
Background The T-SPOT.TB can be read by an ELISPOT plate imager as an alternative to a labor-intensive and time-consuming manual reading, but its accuracy has not been... -
Towards Risk-Based Test Protocols: Estimating the Contribution of Intensive T...
Eradicating disease from livestock populations involves the balancing act of removing sufficient numbers of diseased animals without removing too many healthy individuals in the... -
Geographic Differences in Time to Culture Conversion in Liquid Media: Tubercu...
Background: Tuberculosis Trials Consortium Study 28, was a double blind, randomized, placebo-controlled, phase 2 clinical trial examining smear positive pulmonary Mycobacterium... -
Pharmacist Interventions for Prophylactic Antibiotic Use in Urological Inpati...
OBJECTIVES: To evaluate the impact and cost-benefit value of pharmacist interventions for prophylactic antibiotic use in surgical patients undergoing clean or clean-contaminated... -
Comparison of Quantitative Techniques including Xpert MTB/RIF to Evaluate Myc...
Introduction: Accurate quantification of mycobacterial load is important for the evaluation of patient infectiousness, disease severity and monitoring treatment response in... -
Do black lives matter in public health research and training?
Objective To examine whether investments made in public health research align with the health burdens experienced by white and black Americans. Methods In this... -
Will COVID-19 become the next neglected tropical disease?
The World Health Organization (WHO) currently classifies 20 diseases and conditions as neglected tropical diseases (NTDs). However, since its inception in 2007, PLOS Neglected... -
dedup_wf_001--0c204c910c5a1406b8789ede7ea025eb
Background While some evidence supports the beneficial effects of integrating neglected tropical disease (NTD) programs to optimize coverage and reduce costs, there is minimal... -
What’s coming for health science and policy in 2018? Global experts look ahea...
In PLOS Medicine's first editorial of 2018, editorial board members and other leading researchers share their hopes, pleas, concerns, and expectations for this year in health...